0001213900-14-005339.txt : 20140804 0001213900-14-005339.hdr.sgml : 20140804 20140804092819 ACCESSION NUMBER: 0001213900-14-005339 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140804 DATE AS OF CHANGE: 20140804 EFFECTIVENESS DATE: 20140804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROFECTUS BIOSCIENCES INC CENTRAL INDEX KEY: 0001444253 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-122114 FILM NUMBER: 141011690 BUSINESS ADDRESS: STREET 1: 6411 BECKLEY STREET STREET 2: SUITE N202 CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 443-524-0843 MAIL ADDRESS: STREET 1: 6411 BECKLEY STREET STREET 2: SUITE N202 CITY: BALTIMORE STATE: MD ZIP: 21224 D/A 1 primary_doc.xml X0707 D/A LIVE 0001444253 PROFECTUS BIOSCIENCES INC 6411 BECKLEY STREET SUITE N202 BALTIMORE MD MARYLAND 21224 443-743-1110 DELAWARE Maryland Biotherapeutics Inc. None Corporation true Jeffrey N. Meshulam c/o Beckley Street Suite N201 Baltimore MD MARYLAND 21224 Director Brian K. Adamsky c/o Beckley Street Suite N201 Baltimore MD MARYLAND 21224 Director Michael Greenebaum c/o Beckley Street Suite N201 Baltimore MD MARYLAND 21224 Director William Haseltine c/o Beckley Street Suite N201 Baltimore MD MARYLAND 21224 Director Tom Pease c/o Beckley Street Suite N201 Baltimore MD MARYLAND 21224 Executive Officer Thomas A. Lynch c/o Beckley Street Suite N201 Baltimore MD MARYLAND 21224 Executive Officer 15.61% owner of the Issuer Thomas G. Paese c/o Beckley Street Suite N201 Baltimore MD MARYLAND 21224 Executive Officer Alexander G. Rich c/o Beckley Street Suite N201 Baltimore MD MARYLAND 21224 Executive Officer Director M.G. Sarngaharan c/o Beckley Street Suite N201 Baltimore MD MARYLAND 21224 Executive Officer Frederick C. Tecce c/o 6411 Beckley Street Suite N201 Baltimore MD MARYLAND 21224 Director Biotechnology Decline to Disclose 06b true 0001213900-14-002525 2009-07-20 true true false 0 7541206 7541206 0 Seven tranche investment, with tranche date and investment amount as follows: 7/20/09 $5,041,206.00 3/23/10$1,000,000.80 9/9/10 $500,000.40 7/15/11 $249,999.60 1/22/13 $249,999.60 8/12/13 $500,000.404/8/14 $249,999.60 7/31/2014 250,000.40 true 0 1 0 0 0 false PROFECTUS BIOSCIENCES INC /s/ Jeffrey N. Meshulam Jeffrey N. Meshulam President and COO 2014-08-04